Membership

The Network

ALBA represents a global diverse network of individual neuroscientists who are involved in research, education, communication and advocacy, and are committed to supporting and advocating for actions and policies that foster diversity, equity and inclusion (DEI) in brain sciences across the globe. We currently have 1890 individual members from 91 countries.

Become a member

Register as an ALBA Network member for free! As a member, you can

  • Help shape ALBA's priorities and goals
  • Drive initiatives as an ALBA Volunteer
  • Receive regular updates on ALBA activities and events
  • Have access to DEI skills and advocacy training workshops
  • Engage with the ALBA Team at the General Assembly
  • Elect the members of our Board of Directors
Join the Network

Search our membership database

Browse through the ALBA members to find a speaker for your next
conference, a mentor for guidance, an expert for a new project or to simply network.

Gender
Position
Country

Ioannis
Zalachoras

Postdoctoral fellow at EPFL
Switzerland Website
OrcID
Gender : Man
Fields of research :
Behavioral neuroscience
Cellular and molecular neuroscience
Neuroendocrinology
Analysis of behavior and cognition in non-human animal
Molecular approaches
Pharmacology

Olivia
Zanoletti

Research/Staff scientist at EPFL
Switzerland
Gender : Woman
Fields of research :

Stefanie
Zechner

Other at Science. People. Business.
Switzerland Website
Gender : Woman
Fields of research :
Cognitive neuroscience
Neuroscience of aging
Analysis of behavior and cognition in humans
Electrophysiology (slow waves)
Imaging (PET, fMRI, etc)
I joined ALBA because :
I'm intrigued about ALBA's mission to foster diversity, equity and inclusion in the neuroscience community. I have been serving the Healthcare Businesswomen Association (HBA), an international non-for profit organization to advance DEI in healthcare for many years and in different roles, currently as Advisor in a leadership program for our corporate sponsors.

My background is Neuroscience both from an academic and clinical drug development perspective. As Clinical Trial Head I successfully led a large multi-national neuroscience drug development team and helped to bring the first transdermal patch for dementia associated with Alzheimer's Disease, Exelon Patch, to market. In this process, I found my 2nd passion: developing people and organizations and enabling them to perform so they can advance medicine.

In 2020 I founded Science. People. Business. My mission is to advance healthcare through and with the right people in the right place.
In anticipation of the growing demand of experts and leaders in the Neuroscience R&D space, my ambition is to set up a Neuroscience Center of Excellence in Switzerland.